Deepak Chadha's Insider Trades & SAST Disclosures
Deepak Chadha's most recent trade in Fresh Tracks Therapeutics Inc was a trade of 35,000 Restricted Stock Units done . Disclosure was reported to the exchange on Sept. 1, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Deepak Chadha.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Former Chief R&D Officer & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 35,000 | 0 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Former Chief R&D Officer & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 35,000 | 37,292 (0%) | 0% | - | Common Stock | |
| Fresh Tracks Therapeutics Inc | Chadha Deepak | Former Chief R&D Officer & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 01 Sep 2023 | 14,978 | 22,314 (0%) | 0% | 0.6 | 9,301 | Common Stock |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Chief R&D Officer and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 35,000 | 35,000 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Chief Research & Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 325,000 | 325,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Chief Research & Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Chief Research & Dev. Officer | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 18 May 2021 | 12,500 | 78,167 (0%) | 0% | 0.8 | 10,378 | Common Stock |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Chief Research & Dev. Officer | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 18 May 2021 | 2,700 | 65,667 (0%) | 0% | 0.8 | 2,212 | Common Stock |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Chief Research & Dev. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 25,000 | 71,717 (0%) | 0% | - | Common Stock | |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Chief Research & Dev. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 25,000 | 0 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Chief Research & Dev. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 16 Mar 2021 | 8,750 | 62,967 (0%) | 0% | 1.1 | 9,975 | Common Stock |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Chief Research & Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Chief Research & Dev. Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 26,087 | 46,717 (0%) | 0% | - | Common Stock | |
| Fresh Tracks Therapeutics Inc | Deepak Chadha | Chief Research & Dev. Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 26,087 | 26,087 | - | - | Common Stock Warrants (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges